These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 447784)

  • 1. Adjusting for losses to follow-up in a sample size determination for cohort studies.
    Palta M; McHugh R
    J Chronic Dis; 1979; 32(4):315-26. PubMed ID: 447784
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.
    Lachin JM; Foulkes MA
    Biometrics; 1986 Sep; 42(3):507-19. PubMed ID: 3567285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi.
    Ioannidis JP; Taha TE; Kumwenda N; Broadhead R; Mtimavalye L; Miotti P; Yellin F; Contopoulos-Ioannidis DG; Biggar RJ
    Int J Epidemiol; 1999 Aug; 28(4):769-75. PubMed ID: 10480709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infarct size determination by technetium 99m sestamibi single-photon emission computed tomography predicts survival in patients with chronic coronary artery disease.
    Hurrell DG; Milavetz J; Hodge DO; Gibbons RJ
    Am Heart J; 2000 Jul; 140(1):61-6. PubMed ID: 10874264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concepts in sample size determination.
    Rao UK
    Indian J Dent Res; 2012; 23(5):660-4. PubMed ID: 23422614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample sizes for time-to-event endpoints: should you insure against chance variations in accrual?
    Abel UR; Jensen K; Karapanagiotou-Schenkel I
    Contemp Clin Trials; 2012 Mar; 33(2):456-8. PubMed ID: 22094431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying and Adjusting for Disease Misclassification Due to Loss to Follow-Up in Historical Cohort Mortality Studies.
    Scott LL; Maldonado G
    Int J Environ Res Public Health; 2015 Oct; 12(10):12834-46. PubMed ID: 26501295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The determination of sample size in treatment-control comparisons for chronic disease studies in which drop-out or non-adherence is a problem.
    Schork MA; Remington RD
    J Chronic Dis; 1967 Apr; 20(4):233-9. PubMed ID: 6023231
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic primary glomerulopathy. A design for study of diagnosis and treatment.
    Donadio JV
    Minn Med; 1974 May; 57(5):379-83 passim. PubMed ID: 4824719
    [No Abstract]   [Full Text] [Related]  

  • 10. On pooling across strata when frequency matching has been followed in a cohort study.
    Weinberg CR
    Biometrics; 1985 Mar; 41(1):117-27. PubMed ID: 4005370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trials 5: Determining the sample size and power for clinical trials and cohort studies.
    Greene T
    Methods Mol Biol; 2015; 1281():225-47. PubMed ID: 25694313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A guide to the appraisal of research: 2. What's in a number?
    Bateman G; Burke FJ; Saha S
    Dent Update; 2009 Nov; 36(9):570-2, 575-6. PubMed ID: 20099609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating maximum power losses in survival studies with nonstratified randomization.
    Palta M
    Biometrics; 1985 Jun; 41(2):497-504. PubMed ID: 4027324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies of whiplash trauma critically analyzed].
    Orthopade; 2007 Apr; 36(4):379-80. PubMed ID: 17387447
    [No Abstract]   [Full Text] [Related]  

  • 15. Selection, follow-up, and analysis in prospective studies: a workshop. Proceedings of a conference. New York, N.Y., October 3-5, 1983.
    Natl Cancer Inst Monogr; 1985 May; 67():1-221. PubMed ID: 4047138
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of losses to follow-up on diet/alcohol and lung cancer analyses in the New York State Cohort.
    Bandera EV; Freudenheim JL; Marshall JR; Priore RL; Brasure J; Baptiste M; Graham S
    Nutr Cancer; 2002; 42(1):41-7. PubMed ID: 12235649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size for case-control studies using Cochran's statistic.
    Woolson RF; Bean JA; Rojas PB
    Biometrics; 1986 Dec; 42(4):927-32. PubMed ID: 3814733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HWS-whiplash injury--the doctor is in charge].
    Oppel U
    Orthopade; 2007 Aug; 36(8):761-2. PubMed ID: 17657477
    [No Abstract]   [Full Text] [Related]  

  • 19. Type-II generalized family-wise error rate formulas with application to sample size determination.
    Delorme P; de Micheaux PL; Liquet B; Riou J
    Stat Med; 2016 Jul; 35(16):2687-714. PubMed ID: 26914402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues associated with the design of a national probability sample for human exposure assessment.
    Ezzati-Rice TM; Murphy RS
    Environ Health Perspect; 1995 Apr; 103 Suppl 3(Suppl 3):55-9. PubMed ID: 7635113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.